Capricor Therapeutics, Inc. CAPR
CAPR
Capricor Therapeutics, Inc. CABA
Cabaletta Bio, Inc. LXEO
Lexeo Therapeutics, Inc. Common Stock PRQR
ProQR Therapeutics N.V. TRDA
Entrada Therapeutics, Inc. IMMP
Immutep Limited ALLO
Allogene Therapeutics, Inc. EDIT
Editas Medicine, Inc. ACHV
Achieve Life Sciences, Inc. ARCT
Arcturus Therapeutics Holdings Inc.
Capricor Therapeutics, Inc. CABA
Cabaletta Bio, Inc. LXEO
Lexeo Therapeutics, Inc. Common Stock PRQR
ProQR Therapeutics N.V. TRDA
Entrada Therapeutics, Inc. IMMP
Immutep Limited ALLO
Allogene Therapeutics, Inc. EDIT
Editas Medicine, Inc. ACHV
Achieve Life Sciences, Inc. ARCT
Arcturus Therapeutics Holdings Inc.
Performance
| Periode | CAPR | CABA | LXEO | PRQR | TRDA | IMMP | ALLO | EDIT | ACHV | ARCT |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 114.18 % | 27.06 % | 151.02 % | 28.95 % | 49.66 % | 48.54 % | 10.21 % | 16.44 % | 43.39 % | -43.51 % |
| YTD | 77.24 % | 5.79 % | 47.53 % | -10.58 % | -36.48 % | 14.93 % | -31.37 % | 91.98 % | 20.46 % | -57.41 % |
| 1Y | 91.03 % | -9.04 % | 38.98 % | -0.81 % | -38.42 % | 22.12 % | -26.70 % | 69.93 % | 7.63 % | -55.23 % |
| 3Y | 607.07 % | -63.70 % | -2.09 % | 57.05 % | -47.64 % | 35.11 % | -78.15 % | -75.51 % | 77.80 % | -59.68 % |
| 5Y | 525.35 % | -82.01 % | -2.09 % | -38.90 % | -53.70 % | -23.72 % | -94.43 % | -96.07 % | -44.02 % | -92.84 % |
| 10Y | -25.31 % | -75.35 % | -2.09 % | -66.76 % | -53.70 % | -80.31 % | -93.96 % | -86.18 % | -99.82 % | -82.12 % |
| From the beginning | -94.11 % | -75.35 % | -2.09 % | -83.37 % | -53.70 % | -98.10 % | -93.96 % | -86.18 % | -100.00 % | -86.24 % |